Dr. Reddy's Laboratories Ltd.NSE: DRREDDY

Press Release Sep 07 2022

· Issued by Dr. Reddy's Laboratories Ltd.

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-sep-07-2022-2

Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call · Replay · Jul 22Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call

Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 07-Sep-2022 titled "Dr. Reddy's Laboratories announces the launch of Lenalidomide Capsules in the U.S. with two of six strengths eligible for first-to-market, 180-day exclusivity.

View Attachment

6ix hasn’t read this filing yet.

Dr. Reddy's Laboratories Ltd. on 6ix

Earlier from Dr. Reddy's Laboratories

Later from Dr. Reddy's Laboratories

All Dr. Reddy's Laboratories news releases